MAPT and Alzheimer disease: The radio-induced reduction of amyloid-Aβ42 plaques in AD mice appears to be concomitant with the mitigation of neuroinflammatory cytokine production (CD54, IL-3, CXCL9/10, and CCL2/4) [99,103] and inconsistently with or without the reduction of Tau protein staining [104,105].